Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
07:15am, Monday, 12'th Aug 2024
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they h
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results
07:10am, Monday, 12'th Aug 2024
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of tran
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:36pm, Monday, 05'th Aug 2024
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve th
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
08:29am, Thursday, 01'st Aug 2024
New initiative aims to provide information and resources for teen mental health amidst rising public health concerns New initiative aims to provide information and resources for teen mental health ami
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
08:30am, Tuesday, 30'th Jul 2024
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life
Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call
08:30am, Monday, 29'th Jul 2024
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
08:31am, Monday, 22'nd Jul 2024
Coverage criteria consistent with recent FDA clearance for NeuroStar TMS Coverage criteria consistent with recent FDA clearance for NeuroStar TMS
3 Neurotech Stocks Bridging Mind and Machine
10:30am, Thursday, 18'th Jul 2024
If the prospect of controlling computers and robots with brainpower alone excites you, neurotech stocks are right up your alley. Unfortunately, today's top neurotech company — Elon Musk's Neuralink
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
08:36am, Thursday, 11'th Jul 2024
NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
08:32am, Wednesday, 10'th Jul 2024
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
11:40am, Tuesday, 02'nd Jul 2024
Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts. The BMP program will be part of the company's NeuroStar
NeuroStar® Launches Better Me Provider Program Nationwide
08:02am, Monday, 01'st Jul 2024
The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry The first and only TMS company to establish comprehensive standard
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
08:31am, Thursday, 13'th Jun 2024
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 Early prediction of nonresponse abstract selected for oral presentation as a prest
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
08:30am, Thursday, 23'rd May 2024
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
07:32am, Wednesday, 15'th May 2024
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older
